ATE547525T1 - Lösliche zcyctor 11 cytokinrezeptoren - Google Patents
Lösliche zcyctor 11 cytokinrezeptorenInfo
- Publication number
- ATE547525T1 ATE547525T1 AT10153071T AT10153071T ATE547525T1 AT E547525 T1 ATE547525 T1 AT E547525T1 AT 10153071 T AT10153071 T AT 10153071T AT 10153071 T AT10153071 T AT 10153071T AT E547525 T1 ATE547525 T1 AT E547525T1
- Authority
- AT
- Austria
- Prior art keywords
- zcyctor
- soluble
- cytokine receptors
- receptor
- antagonist
- Prior art date
Links
- 102000003675 cytokine receptors Human genes 0.000 title 1
- 108010057085 cytokine receptors Proteins 0.000 title 1
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108010054016 IL-TIF IL-10-related T cell-derived inducible factor Proteins 0.000 abstract 1
- 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 abstract 1
- 101710199214 Interleukin-10 receptor subunit beta Proteins 0.000 abstract 1
- 102100030703 Interleukin-22 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 108010074109 interleukin-22 Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Photoreceptors In Electrophotography (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22382700P | 2000-08-08 | 2000-08-08 | |
US25087600P | 2000-12-01 | 2000-12-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE547525T1 true ATE547525T1 (de) | 2012-03-15 |
Family
ID=26918167
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01970531T ATE342980T1 (de) | 2000-08-08 | 2001-08-08 | Lösliche zcyctor 11 cytokinrezeptoren |
AT10153071T ATE547525T1 (de) | 2000-08-08 | 2001-08-08 | Lösliche zcyctor 11 cytokinrezeptoren |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01970531T ATE342980T1 (de) | 2000-08-08 | 2001-08-08 | Lösliche zcyctor 11 cytokinrezeptoren |
Country Status (9)
Country | Link |
---|---|
US (5) | US7045498B2 (de) |
EP (2) | EP1337636B1 (de) |
JP (1) | JP5015404B2 (de) |
AT (2) | ATE342980T1 (de) |
AU (1) | AU2001290524A1 (de) |
CA (1) | CA2418950A1 (de) |
DE (1) | DE60123998T2 (de) |
ES (1) | ES2381650T3 (de) |
WO (1) | WO2002012345A2 (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
AU2001290524A1 (en) * | 2000-08-08 | 2002-02-18 | Zymogenetics Inc. | Soluble zcytor 11 cytokine receptors |
ATE333888T1 (de) | 2000-09-15 | 2006-08-15 | Zymogenetics Inc | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen |
US7094570B2 (en) | 2003-03-11 | 2006-08-22 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules which encode a soluble IL-TIF/IL-22 receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
AU2002249948B2 (en) | 2001-01-12 | 2007-08-23 | Genetics Institute, Llc | Type 2 cytokine receptor and nucleic acids encoding same |
AU2002357283B2 (en) | 2001-12-17 | 2007-08-16 | Zymogenetics, Inc. | Method for treating cervical cancer |
EP1575513A4 (de) * | 2002-08-16 | 2007-04-04 | Wyeth Corp | Zusammensetzungen und verfahren zur behandlung von mit rage zusammenhängenden erkrankungen |
JP2007525437A (ja) * | 2003-03-24 | 2007-09-06 | ザイモジェネティクス, インコーポレイテッド | 抗il−20抗体および結合パートナーならびに炎症において用いる方法 |
CN1798768B (zh) * | 2003-03-24 | 2013-05-08 | 津莫吉尼蒂克斯公司 | 抗il-22ra抗体和结合伴侣及其应用 |
WO2005052001A2 (en) | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
AU2005299809B2 (en) | 2004-10-22 | 2010-12-02 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
WO2006058024A2 (en) * | 2004-11-22 | 2006-06-01 | Smith Henry J | Cellular receptors used in the treatment of inflammatory disease |
JP2008532931A (ja) | 2005-02-08 | 2008-08-21 | ザイモジェネティクス, インコーポレイテッド | 抗il−20、抗il−22および抗il−22ra抗体ならびに結合パートナー、ならびに炎症における使用法 |
EP3683230A1 (de) | 2005-05-12 | 2020-07-22 | ZymoGenetics, Inc. | Zusammensetzungen und verfahren zur modulation von immunsystemreaktionen |
US7180469B2 (en) * | 2005-06-29 | 2007-02-20 | Cushcraft Corporation | System and method for providing antenna radiation pattern control |
JP5368301B2 (ja) | 2006-06-22 | 2013-12-18 | ノボ・ノルデイスク・エー/エス | 可溶性ヘテロ二量体レセプター及びその使用 |
KR101361355B1 (ko) | 2007-06-14 | 2014-02-12 | 갈락티카 파마슈티칼스, 인크. | Rage 융합 단백질 |
US9238878B2 (en) | 2009-02-17 | 2016-01-19 | Redwood Bioscience, Inc. | Aldehyde-tagged protein-based drug carriers and methods of use |
CN107496917B (zh) | 2010-02-26 | 2021-06-11 | 诺沃—诺迪斯克有限公司 | 包含稳定抗体的组合物 |
WO2011147921A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
AU2012205301B2 (en) | 2011-01-14 | 2017-01-05 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
CN109071634A (zh) | 2016-04-26 | 2018-12-21 | R.P.谢勒技术有限责任公司 | 抗体偶联物及其制备和使用方法 |
JP7439372B2 (ja) * | 2018-06-21 | 2024-02-28 | シャタック ラボ,インコーポレイテッド | ヘテロ二量体タンパク質及びその使用 |
CN117425674A (zh) * | 2021-03-02 | 2024-01-19 | 丹娜法伯癌症研究院 | 治疗红细胞疾患的方法 |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654090A (en) * | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
WO1989004838A1 (en) * | 1987-11-25 | 1989-06-01 | Immunex Corporation | Interleukin-1 receptors |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US5567584A (en) * | 1988-01-22 | 1996-10-22 | Zymogenetics, Inc. | Methods of using biologically active dimerized polypeptide fusions to detect PDGF |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5436155A (en) * | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
US5789192A (en) | 1992-12-10 | 1998-08-04 | Schering Corporation | Mammalian receptors for interleukin-10 (IL-10) |
CA2258721C (en) * | 1996-07-12 | 2014-09-09 | Genentech, Inc. | Chimeric heteromultimer adhesins |
US5843697A (en) * | 1996-07-17 | 1998-12-01 | University Of Medicine And Dentistry Of New Jersey | Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein |
US5985614A (en) * | 1996-08-30 | 1999-11-16 | Human Genome Sciences, Inc. | Polynucleotides encoding interleukin-19 |
US5945511A (en) * | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
JP2001510035A (ja) | 1997-07-16 | 2001-07-31 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | インターロイキン−20 |
US6486301B1 (en) | 1997-07-16 | 2002-11-26 | Human Genome Sciences, Inc. | Interleukin-20 |
US5965704A (en) * | 1997-08-05 | 1999-10-12 | Zymogenetics, Inc. | Class two cytokine receptor-11 |
US6020163A (en) * | 1997-08-06 | 2000-02-01 | Zymogenetics, Inc. | Lipocalin homolog |
BR9814904A (pt) | 1997-11-26 | 2000-10-03 | Zymogenetics Inc | Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo. |
US6576743B1 (en) * | 1997-11-26 | 2003-06-10 | Zymogenetics, Inc. | Mammalian cytokine-like polypeptide-10 |
IL137178A0 (en) | 1998-01-23 | 2001-07-24 | Immunex Corp | Il-18 receptors |
CA2323236A1 (en) | 1998-03-09 | 1999-09-16 | Schering Corporation | Human receptor proteins; related reagents and methods |
NZ507435A (en) | 1998-03-10 | 2003-12-19 | Genentech Inc | Novel polypeptides and nucleic acids with homology to cornichon |
US6982320B2 (en) | 1998-03-19 | 2006-01-03 | Human Genome Sciences, Inc. | Cytokine receptor common gamma chain like |
AU5203199A (en) | 1998-05-26 | 1999-12-13 | Procter & Gamble Company, The | Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system |
DE69911793T2 (de) * | 1998-07-28 | 2004-08-12 | Micromet Ag | Heterominikörper |
CA2339043A1 (en) | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Further pro polypeptides and sequences thereof |
US6472179B2 (en) * | 1998-09-25 | 2002-10-29 | Regeneron Pharmaceuticals, Inc. | Receptor based antagonists and methods of making and using |
BR9914777A (pt) | 1998-10-26 | 2001-07-03 | Ludwig Inst Cancer Res | Moléculas isoladas de ácido nucléico que codificam os fatores induzìveis por células t (tifs), as proteìnas codificadas e os usos das mesmas |
US6274710B1 (en) * | 1998-10-26 | 2001-08-14 | Ludwig Institute For Cancer Research | Antibodies which specifically bind T Cell inducible factors (TIFs) |
EP1141008A1 (de) * | 1998-12-31 | 2001-10-10 | Millennium Pharmaceuticals, Inc. | Cytokinin klasse ii rezeptor-ähnliche proteine und für diese kodierende nukleinsäuren |
DK1177312T3 (da) | 1999-04-28 | 2008-02-25 | Genetics Inst Llc | Humane GIL-19/AE289-proteiner og polynukleotider kodende derfor |
CA2373231A1 (en) | 1999-05-19 | 2000-11-23 | Incyte Genomics, Inc. | Extracellular signaling molecules |
AU5047600A (en) | 1999-05-27 | 2000-12-18 | Schering Corporation | Mammalian interleukin-10 homologs: il-d110 and il-d210 |
EP1208195A2 (de) | 1999-06-15 | 2002-05-29 | Genentech Inc. | Ausgeschiedene und transmembran-polypeptide und dafür kodierende nukleinsäure |
AU2883700A (en) | 1999-06-23 | 2001-01-09 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
DK1860188T3 (da) | 1999-07-07 | 2011-06-27 | Zymogenetics Inc | Human cytokin-receptor |
AU7573000A (en) * | 1999-09-01 | 2001-03-26 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
MXPA02005058A (es) | 1999-11-18 | 2002-11-07 | Schering Corp | Proteinas de mamiferos receptoras, reactivos y metodos relacionados. |
EP1234035B1 (de) * | 1999-12-03 | 2010-02-24 | ZymoGenetics, Inc. | Menschliches zytokinrezeptor |
DK1246846T3 (da) | 1999-12-23 | 2008-12-08 | Zymogenetics Inc | Oplöselig interleukin-20-receptor |
JP2003524415A (ja) | 1999-12-23 | 2003-08-19 | ザイモジェネティクス,インコーポレイティド | サイトカインzcyto18 |
US6610286B2 (en) * | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
EP2295078A3 (de) | 1999-12-23 | 2011-03-23 | ZymoGenetics, L.L.C. | Verfahren zur Behandlung von Entzündungen |
NZ523122A (en) | 2000-06-22 | 2004-06-25 | Smithkline Beecham Corp | Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases |
AU2001290524A1 (en) * | 2000-08-08 | 2002-02-18 | Zymogenetics Inc. | Soluble zcytor 11 cytokine receptors |
EP2298789B1 (de) | 2000-09-08 | 2012-03-14 | Schering Corporation | Gene von Säugetiere, und damit verbundene Reagentien, Methoden |
ATE333888T1 (de) * | 2000-09-15 | 2006-08-15 | Zymogenetics Inc | Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen |
US7268223B2 (en) | 2000-09-22 | 2007-09-11 | Wyeth | Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
US20030022827A1 (en) * | 2000-09-25 | 2003-01-30 | Bertram Weiss | Three new members of the cytokine receptor family class 2 |
AU2002249948B2 (en) | 2001-01-12 | 2007-08-23 | Genetics Institute, Llc | Type 2 cytokine receptor and nucleic acids encoding same |
WO2002058724A2 (en) | 2001-01-26 | 2002-08-01 | Eli Lilly And Company | Use of lp82 to treat body weight disorders |
JP2005510451A (ja) | 2001-02-23 | 2005-04-21 | ジェネティクス インスティテュート,エルエルシー | 炎症性障害を治療するための組成物及び方法 |
CN1503677A (zh) | 2001-02-28 | 2004-06-09 | 用lp82治疗造血障碍 | |
US6875845B2 (en) * | 2001-03-02 | 2005-04-05 | Zymogenetics, Inc. | Mouse cytokine receptor |
AU2002245652A1 (en) | 2001-03-09 | 2002-09-24 | Zymogenetics, Inc. | Soluble heterodimeric cytokine receptor |
US20040086908A1 (en) * | 2002-03-07 | 2004-05-06 | Chandrasekher Yasmin A. | Soluble heterodimeric cytokine receptor |
AU2002252460A1 (en) | 2001-03-27 | 2002-10-08 | Zymogenetics, Inc. | Human cytokine receptor |
US20040204351A1 (en) | 2001-10-22 | 2004-10-14 | Rowlinson Scott William | Soluble proteins that inhibit cytokine signal transduction pathways |
DE10154579A1 (de) | 2001-11-07 | 2003-05-28 | Medigene Ag | Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen |
AU2002357283B2 (en) | 2001-12-17 | 2007-08-16 | Zymogenetics, Inc. | Method for treating cervical cancer |
US20040236075A1 (en) * | 2002-07-24 | 2004-11-25 | Laure Dumoutier | Novel glass II cytokine receptors, and uses thereof |
JP2007525437A (ja) | 2003-03-24 | 2007-09-06 | ザイモジェネティクス, インコーポレイテッド | 抗il−20抗体および結合パートナーならびに炎症において用いる方法 |
WO2005052001A2 (en) * | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Anti-il-20 receptor antibodies and binding partners and methods of using in inflammation |
AU2005299809B2 (en) * | 2004-10-22 | 2010-12-02 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
-
2001
- 2001-08-08 AU AU2001290524A patent/AU2001290524A1/en not_active Abandoned
- 2001-08-08 EP EP01970531A patent/EP1337636B1/de not_active Expired - Lifetime
- 2001-08-08 US US09/925,055 patent/US7045498B2/en not_active Expired - Lifetime
- 2001-08-08 DE DE60123998T patent/DE60123998T2/de not_active Expired - Lifetime
- 2001-08-08 WO PCT/US2001/024838 patent/WO2002012345A2/en active IP Right Grant
- 2001-08-08 JP JP2002518316A patent/JP5015404B2/ja not_active Expired - Fee Related
- 2001-08-08 AT AT01970531T patent/ATE342980T1/de active
- 2001-08-08 CA CA002418950A patent/CA2418950A1/en not_active Abandoned
- 2001-08-08 AT AT10153071T patent/ATE547525T1/de active
- 2001-08-08 EP EP10153071A patent/EP2177616B1/de not_active Expired - Lifetime
- 2001-08-08 ES ES10153071T patent/ES2381650T3/es not_active Expired - Lifetime
-
2005
- 2005-11-15 US US11/274,910 patent/US20060068471A1/en not_active Abandoned
-
2009
- 2009-06-22 US US12/489,236 patent/US20100047168A1/en not_active Abandoned
-
2010
- 2010-11-10 US US12/943,181 patent/US8287866B2/en not_active Expired - Lifetime
-
2012
- 2012-09-13 US US13/613,697 patent/US20130028894A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2177616B1 (de) | 2012-02-29 |
CA2418950A1 (en) | 2002-02-14 |
DE60123998T2 (de) | 2007-09-06 |
US7045498B2 (en) | 2006-05-16 |
US20030157096A1 (en) | 2003-08-21 |
WO2002012345A2 (en) | 2002-02-14 |
EP1337636A2 (de) | 2003-08-27 |
AU2001290524A1 (en) | 2002-02-18 |
JP5015404B2 (ja) | 2012-08-29 |
US8287866B2 (en) | 2012-10-16 |
EP2177616A1 (de) | 2010-04-21 |
DE60123998D1 (de) | 2006-11-30 |
WO2002012345A3 (en) | 2003-06-12 |
US20060068471A1 (en) | 2006-03-30 |
ES2381650T3 (es) | 2012-05-30 |
US20110081344A1 (en) | 2011-04-07 |
US20130028894A1 (en) | 2013-01-31 |
JP2004505641A (ja) | 2004-02-26 |
EP1337636B1 (de) | 2006-10-18 |
ATE342980T1 (de) | 2006-11-15 |
US20100047168A1 (en) | 2010-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE547525T1 (de) | Lösliche zcyctor 11 cytokinrezeptoren | |
CY1112787T1 (el) | Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17 | |
CY1106594T1 (el) | Αντισωματα εναντι ανθρωπινης il-12 | |
DK0931092T3 (da) | Varianter af vækstfaktor for vaskulære endotelceller med antagonistiske egenskaber | |
DE60141234D1 (de) | Löslicher Zytokinrezeptor zalpfa11 | |
PT1066380E (pt) | Receptor de celula t soluvel | |
DK1135153T3 (da) | Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser | |
EA200301117A1 (ru) | Антитела против vla-1 | |
ATE241008T1 (de) | Monoklonale antikörper gegen den interferonrezeptor, mit neutralisierender aktivität gegen typ i-interferon | |
RU2008102979A (ru) | Терапевтическое средство для заболеваний, родственных детским хроническим артритным заболеваниям | |
ATE187982T1 (de) | Cytokine antagoniste | |
RU2006126092A (ru) | Профилактическое средство против васкулита | |
ATE516305T1 (de) | Il-15-bindungsstelle für il-15-ralpha und spezifische il-15-mutanten mit wirkung als agonisten/antagonisten | |
EA200500441A1 (ru) | Терапевтическое человеческое моноклональное антитело против il-1r1 | |
TR200202253T2 (tr) | IL-18 Kaynaklı rahatsızlıkların tedavisinde faydalı rekombinant IL-18 antagonistleri | |
DK1399472T3 (da) | Oplöselig heterodimer cytokinreceptor | |
RU2010146161A (ru) | Применение блокаторов интерферона типа i для профилактики и лечения псориаза | |
TR199901636T2 (xx) | �mm�nolojik hastal�klar�n tedavisi i�in terap�tik maddeler olarak ��z�n�r lenfotoksin-beta resept�rleri, anti-lenfotoksin resept�r� antikorlar� ve anti-lenfotoksin ba�� antikorlar�. | |
ATE542138T1 (de) | Her-2-bindungsantagonisten | |
BR9815335A (pt) | Uso de antagonistas de receptor de endotelina. | |
ATE442387T1 (de) | Dimerisierter t-zell rezeptor fragment, dessen zusammensetzungen und verwendung | |
JP2006528663A5 (de) | ||
EP1736545A3 (de) | Lösliche Zcyctor 11 Cytokinrezeptoren | |
WO2002077153A3 (en) | The human psychosine receptor |